News Changing Faces: Pharma-adjacent hires from February 2023 Combining an agency and consultancy roundup with a digital and supplier roundup.
News Changing Faces: Pharma-adjacent hires in Dec ’22 and Jan ’23 December and January also saw hires in digital health companies and pharm-adjacent industries
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.